Dapsone labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Labels And Packages== | ==Labels And Packages== | ||
Principal Display Panel – 25 mg Carton Label | ===Principal Display Panel – 25 mg Carton Label=== | ||
NDC 49938-102-30 | NDC 49938-102-30 | ||
| Line 18: | Line 18: | ||
Rx Only | Rx Only | ||
To be sold as a single unit | To be sold as a single unit | ||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
===Principal Display Panel – 100 mg Carton Label=== | |||
NDC 49938-101-30 | |||
DAPSONE | |||
Tablets USP | |||
100 mg | |||
30 Tablets (2 x 15 unit of use) | |||
Rx Only | |||
To be sold as a single unit<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DAPSONE TABLET [JACOBUS PHARMACEUTICAL COMPANY, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0792169d-c6f9-4af0-93ae-b75d710c47a9 | publisher = | date = | accessdate = }}</ref> | |||
{| | {| | ||
| Line 28: | Line 47: | ||
|} | |} | ||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
Latest revision as of 22:50, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
Principal Display Panel – 25 mg Carton Label
NDC 49938-102-30
DAPSONE
Tablets USP
25 mg
30 Tablets (2 x 15 unit of use)
Rx Only
To be sold as a single unit
| [[File:|800px|thumb]] |
Principal Display Panel – 100 mg Carton Label
NDC 49938-101-30
DAPSONE
Tablets USP
100 mg
30 Tablets (2 x 15 unit of use)
Rx Only
To be sold as a single unit[1]
| [[File:|800px|thumb]] |
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.